{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:36:24Z","timestamp":1791308184470,"version":"4.3.1"},"reference-count":25,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.3892\/or.2013.2803","type":"journal-article","created":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T10:37:56Z","timestamp":1382438276000},"page":"27-33","source":"Crossref","is-referenced-by-count":23,"title":["ERC\/mesothelin is expressed in human gastric cancer tissues and cell lines"],"prefix":"10.3892","volume":"31","author":[{"given":"TOMOAKI","family":"ITO","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUNORI","family":"KAJINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAAKI","family":"ABE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KOICHI","family":"SATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROSHI","family":"MAEKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MUTSUMI","family":"SAKURADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAJIME","family":"ORITA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RYO","family":"WADA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YOSHIAKI","family":"KAJIYAMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OKIO","family":"HINO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,10,22]]},"reference":[{"key":"key20180107222938_b1-or-31-01-0027","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/BF01197777","article-title":"Renal carcinogenesis in the Eker rat","volume":"121","author":"Hino","year":"1995","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20180107222938_b2-or-31-01-0027","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1006\/bbrc.2000.3280","article-title":"Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model","volume":"275","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107222938_b3-or-31-01-0027","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/1566524043359692","article-title":"Multistep renal carcinogenesis in the Eker (Tsc 2 gene mutant) rat model","volume":"4","author":"Hino","year":"2004","journal-title":"Curr Mol Med"},{"key":"key20180107222938_b4-or-31-01-0027","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107222938_b5-or-31-01-0027","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1158\/1078-0432.CCR-03-0801","article-title":"Mesothelin: a new target for immunotherapy","volume":"10","author":"Hassan","year":"2004","journal-title":"Clin Cancer Res"},{"key":"key20180107222938_b6-or-31-01-0027","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1158\/1078-0432.CCR-05-1477","article-title":"Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer","volume":"12","author":"Hassan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107222938_b7-or-31-01-0027","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1349-7006.2006.00246.x","article-title":"Novel ELISA system for detection of N-ERC\/mesothelin in the sera of mesothelioma patients","volume":"97","author":"Shiomi","year":"2006","journal-title":"Cancer Sci"},{"key":"key20180107222938_b8-or-31-01-0027","first-page":"1375","article-title":"Secretion of N-ERC\/mesothelin and expression of C-ERC\/mesothelin in human pancreatic ductal carcinoma","volume":"20","author":"Inami","year":"2008","journal-title":"Oncol Rep"},{"key":"key20180107222938_b9-or-31-01-0027","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1158\/1078-0432.CCR-07-1613","article-title":"Sensitive and specific new enzyme-linked immunosorbent assay for N-ERC\/mesothelin increases its potential as a useful serum tumor marker for mesothelioma","volume":"14","author":"Shiomi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107222938_b10-or-31-01-0027","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1158\/1078-0432.CCR-05-1397","article-title":"Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma","volume":"12","author":"Yen","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107222938_b11-or-31-01-0027","first-page":"3862","article-title":"Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)","volume":"7","author":"Argani","year":"2001","journal-title":"Clin Cancer Res"},{"key":"key20180107222938_b12-or-31-01-0027","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000329063","article-title":"Prognostic impact of phosphorylated mitogen-activated protein kinase expression in patients with metastatic gastric cancer","volume":"80","author":"Atmaca","year":"2011","journal-title":"Oncology"},{"key":"key20180107222938_b13-or-31-01-0027","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1177\/147323001204000309","article-title":"Clinicopathological significance of mesothelin expression in invasive breast cancer","volume":"40","author":"Wang","year":"2012","journal-title":"J Int Med Res"},{"key":"key20180107222938_b14-or-31-01-0027","article-title":"C-ERC\/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma","author":"Kawamata","year":"2013","journal-title":"J Gastroenterol"},{"key":"key20180107222938_b15-or-31-01-0027","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.nano.2008.06.006","article-title":"Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy","volume":"4","author":"Alvarez","year":"2008","journal-title":"Nanomedicine"},{"key":"key20180107222938_b16-or-31-01-0027","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1073\/pnas.96.20.11531","article-title":"Soluble member(s) of the mesothelin\/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma","volume":"96","author":"Scholler","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107222938_b17-or-31-01-0027","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jso.22024","article-title":"Mesothelin expression correlates with prolonged patient survival in gastric cancer","volume":"105","author":"Baba","year":"2012","journal-title":"J Surg Oncol"},{"key":"key20180107222938_b18-or-31-01-0027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/bjc.2012.235","article-title":"Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer","volume":"107","author":"Einama","year":"2012","journal-title":"Br J Cancer"},{"key":"key20180107222938_b19-or-31-01-0027","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s12199-007-0014-9","article-title":"Diagnostic tumor marker of asbestos-related mesothelioma","volume":"13","author":"Hino","year":"2008","journal-title":"Environ Health Prev Med"},{"key":"key20180107222938_b20-or-31-01-0027","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0003-2697(87)90021-2","article-title":"Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction","volume":"162","author":"Chomczynski","year":"1987","journal-title":"Anal Biochem"},{"key":"key20180107222938_b21-or-31-01-0027","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1440-1827.2009.02344.x","article-title":"Establishment of novel mAb to human ERC\/mesothelin useful for study and diagnosis of ERC\/mesothelin-expressing cancers","volume":"59","author":"Ishikawa","year":"2009","journal-title":"Pathol Int"},{"key":"key20180107222938_b22-or-31-01-0027","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1158\/1078-0432.CCR-06-0472","article-title":"Megakaryocyte potentiation factor cleaved from mesothelin precursor is a useful tumor marker in the serum of patients with mesothelioma","volume":"12","author":"Onda","year":"2006","journal-title":"Clin Cancer Res"},{"key":"key20180107222938_b23-or-31-01-0027","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3892\/ol.2012.796","article-title":"The utility of serum N-ERC\/mesothelin as a biomarker of ovarian carcinoma","volume":"4","author":"Saeki","year":"2012","journal-title":"Oncol Lett"},{"key":"key20180107222938_b24-or-31-01-0027","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1515\/cclm.2011.816","article-title":"Serum mesothelin and megakaryocyte potentiating factor in pancreatic and biliary cancers","volume":"50","author":"Sharon","year":"2012","journal-title":"Clin Chem Lab Med"},{"key":"key20180107222938_b25-or-31-01-0027","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/1078-0432.CCR-10-1929","article-title":"Serum soluble mesothelin concentrations in malignant pleural mesothelioma: relationship to tumor volume, clinical stage and changes in tumor burden","volume":"17","author":"Creaney","year":"2011","journal-title":"Clin Cancer Res"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2803\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T02:36:36Z","timestamp":1564540596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,10,22]]},"published-print":{"date-parts":[[2014,1]]}},"alternative-id":["10.3892\/or.2013.2803"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2803","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,22]]}}}